450 related articles for article (PubMed ID: 9217771)
1. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities.
Michel M; Gutmann L
Lancet; 1997 Jun; 349(9069):1901-6. PubMed ID: 9217771
[TBL] [Abstract][Full Text] [Related]
2. [Infections of vancomycin resistant enterococci (VRE) and Staphylococcus aureus (VRSA)].
Kuwahara K; Hanaki H; Hiramatsu K
Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):182-5. PubMed ID: 10088368
[No Abstract] [Full Text] [Related]
3. Antibiotic resistance. Epidemiology of resistance in intensive therapy units (ITUs).
Fraise AP
J Med Microbiol; 1997 Jun; 46(6):447-9. PubMed ID: 9379471
[No Abstract] [Full Text] [Related]
4. Vancomycin resistance in gram-positive cocci--old bugs, new tricks, confusing terminology.
Jones AR; Venkatesh B; Lipman J
Anaesth Intensive Care; 1999 Aug; 27(4):396-9. PubMed ID: 10470396
[No Abstract] [Full Text] [Related]
5. Control of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus in hospitalized children.
Fisher MC
Pediatr Infect Dis J; 1998 Sep; 17(9):825-6. PubMed ID: 9779772
[No Abstract] [Full Text] [Related]
6. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
Nordmann P; Naas T; Fortineau N; Poirel L
Curr Opin Microbiol; 2007 Oct; 10(5):436-40. PubMed ID: 17765004
[TBL] [Abstract][Full Text] [Related]
7. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Nelson RR
Lancet; 1997 Nov; 350(9087):1327. PubMed ID: 9357432
[No Abstract] [Full Text] [Related]
8. Sitafloxacin in the treatment of patients with infections caused by vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus.
Shetty N; Wilson AP
J Antimicrob Chemother; 2000 Oct; 46(4):633-8. PubMed ID: 11020265
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci.
Eliopoulos GM
Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):826-31. PubMed ID: 16315008
[TBL] [Abstract][Full Text] [Related]
10. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
[TBL] [Abstract][Full Text] [Related]
11. Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil.
Panesso D; Planet PJ; Diaz L; Hugonnet JE; Tran TT; Narechania A; Munita JM; Rincon S; Carvajal LP; Reyes J; Londoño A; Smith H; Sebra R; Deikus G; Weinstock GM; Murray BE; Rossi F; Arthur M; Arias CA
Emerg Infect Dis; 2015 Oct; 21(10):1844-8. PubMed ID: 26402569
[TBL] [Abstract][Full Text] [Related]
12. [Update of antimicrobial resistance in Gram-positive microorganisms].
Cercenado E
Med Clin (Barc); 2010 Dec; 135 Suppl 3():10-5. PubMed ID: 21477699
[TBL] [Abstract][Full Text] [Related]
13. Enterococci and vancomycin resistance.
French GL
Clin Infect Dis; 1998 Aug; 27 Suppl 1():S75-83. PubMed ID: 9710674
[TBL] [Abstract][Full Text] [Related]
14. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.
Sakoulas G; Moellering RC; Eliopoulos GM
Clin Infect Dis; 2006 Jan; 42 Suppl 1():S40-50. PubMed ID: 16323119
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin-resistant enterococci. Mechanism and clinical relevance.
Eliopoulos GM
Infect Dis Clin North Am; 1997 Dec; 11(4):851-65. PubMed ID: 9421703
[TBL] [Abstract][Full Text] [Related]
16. Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin-rifampicin combination therapy in an intensive care unit.
Ju O; Woolley M; Gordon D
Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):61-2. PubMed ID: 16331332
[No Abstract] [Full Text] [Related]
17. In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
Patel R; Rouse MS; Piper KE; Steckelberg JM
Diagn Microbiol Infect Dis; 2000 Nov; 38(3):177-9. PubMed ID: 11109018
[TBL] [Abstract][Full Text] [Related]
18. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.
Sieradzki K; Roberts RB; Haber SW; Tomasz A
N Engl J Med; 1999 Feb; 340(7):517-23. PubMed ID: 10021472
[No Abstract] [Full Text] [Related]
19. Vancomycin resistance: occurrence, mechanisms and strategies to combat it.
Boneca IG; Chiosis G
Expert Opin Ther Targets; 2003 Jun; 7(3):311-28. PubMed ID: 12783569
[TBL] [Abstract][Full Text] [Related]
20. Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Jul; 46(27):624-6. PubMed ID: 9218648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
